forty-five variant angina patients given a mean daily dose of 78 mg experienced a reduction from 2.6 to 0.28 attacks per day ( p < 0.001 ) , confirmed by in-hospital ergonovine testing ( 22 patients ) and outpatient 24-hour holter monitoring ( 28 patients ) .
C0002963
variant angina
C0014704
ergonovine